DB
CAH icon

Dmitry Balyasny’s Cardinal Health CAH Stock Holding History

Dmitry Balyasny’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,000
Closed -$667K – 2809
2022
Q3 		$667K Buy
+10,000
New +$634K ﹤0.01% 1951
2018
Q4 		– Sell
-80,000
Closed -$4.32M – 1426
2018
Q3 		$4.32M Buy
+80,000
New +$4.09M 0.02% 754
2018
Q1 		– Sell
-350,000
Closed -$21.4M – 1965
2017
Q4 		$21.4M Buy
+350,000
New +$21.6M 0.07% 377
2017
Q1 		– Sell
-113,300
Closed -$8.15M – 1598
2016
Q4 		$8.15M Buy
+113,300
New +$8.19M 0.04% 543

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Dmitry Balyasny's CAH Position: Q2 2026 in Review

Dmitry Balyasny reduced its Cardinal Health (CAH) stake by 3.5% in Q2 2026, selling an estimated $1.03M and leaving 138,588 shares worth $32.9M. The position accounts for 0.04% of the portfolio, ranked #505.

Dmitry Balyasny first reported a position in CAH in Q2 2013 and has held it in 38 quarters since. The position peaked at $110M in Q1 2025. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Dmitry Balyasny held 138,588 shares of Cardinal Health worth $32.9M as of Q2 2026.
  • Dmitry Balyasny sold 4,972 Cardinal Health shares in Q2 2026, an estimated $1.03M.
  • Cardinal Health made up 0.04% of Dmitry Balyasny's portfolio in Q2 2026, its #505 holding.
  • Dmitry Balyasny first reported a position in Cardinal Health in Q2 2013 and has held it in 38 quarters since.
  • Dmitry Balyasny's Cardinal Health position peaked at $110M in Q1 2025.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.